Altano Capital focuses on buyout opportunities and minority investments in early to midstage companies that are involved in developing innovative medical devices and healthcare solutions. The firm is particularly interested in companies that are poised to expand internationally, especially into the U.S. and China. Their portfolio includes companies working on cardiovascular products, structural heart implants, and various medical devices that are in clinical trials or early commercialization stages.